ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy

BACKGROUND: Interleukin-2 (IL-2) plays a pivotal role in immune homeostasis due to its ability to stimulate numerous lymphocyte subsets including natural killer (NK) cells, effector CD4(+) and CD8(+) T cells, and regulatory T cells (T(regs)). Low concentrations of IL-2 induce signaling through the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Jared E, Fisher, Jan L, Flick, Heather L, Wang, Chunhua, Sun, Lei, Ernstoff, Marc S, Alvarez, Juan C, Losey, Heather C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204809/
https://www.ncbi.nlm.nih.gov/pubmed/32317293
http://dx.doi.org/10.1136/jitc-2020-000673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204809/
https://www.ncbi.nlm.nih.gov/pubmed/32317293
http://dx.doi.org/10.1136/jitc-2020-000673

Ejemplares similares